Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annie Jean
Institution:
University of Colorado Anschutz
Observed institutions:
The University of Texas MD Anderson Cancer Center,
University of Colorado Health,
University of Colorado Anschutz,
University of Colorado Denver
ORCID:
0009-0000-8266-5695
Observed ORCID:
0009-0000-8266-5695
OpenAlex ID:
A5109602554
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
2014
·
Dawn R Cochrane
, Sebastián Bernales
, et al.
·
Breast Cancer Research
·
454
PDF
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
2020
·
Megan M. Tu
, Hany A. Abdel-Hafiz
, et al.
·
Communications Biology
·
201
PDF
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease
2008
·
Meenakshi Singh
, Nicole S Spoelstra
, et al.
·
Modern Pathology
·
145
PDF
Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2012
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
·
Molecular Cancer Therapeutics
·
131
A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer
2018
·
Andrew Goodspeed
, Annie Jean
, et al.
·
European Urology
·
97
PDF
Ras Signaling and Transcriptional Synergy at a Flexible Ets-1/Pit-1 Composite DNA Element Is Defined by the Assembly of Selective Activation Domains
2003
·
Dawn L. Duval
, Annie Jean
, et al.
·
Journal of Biological Chemistry
·
24
A Pit-1 Threonine 220 Phosphomimic Reduces Binding to Monomeric DNA Sites to Inhibit Ras and Estrogen Stimulation of the Prolactin Gene Promoter
2009
·
Annie Jean
, Arthur Gutierrez-Hartmann
, et al.
·
Molecular Endocrinology
·
21
PDF
Differential Utilization of Transcription Activation Subdomains by Distinct Coactivators Regulates Pit-1 Basal and Ras Responsiveness
2006
·
Dawn L. Duval
, Matthew D. Jonsen
, et al.
·
Molecular Endocrinology
·
13
PDF
NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
·
Cancer Research
·
11
PDF
A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition
2018
·
Andrew Goodspeed
, Annie Jean
, et al.
·
Bladder Cancer
·
9
PDF
Effect of MDV3100, an androgen receptor signaling inhibitor, on tumor growth of estrogen and androgen receptor-positive (ER+/AR+) breast cancer xenografts.
2012
·
Anthony D. Elias
, Dawn R. Cochrane
, et al.
·
Journal of Clinical Oncology
·
3
Supplementary Tables from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Tables from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Figures from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Data from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Table from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Tables from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Tables from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Data from NPEPPS Is a Druggable Driver of Platinum Resistance
2024
·
Robert T. Jones
, Mathijs Scholtes
, et al.
Supplementary Figure 3 from Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2023
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
PDF
Supplementary Figure Legend from Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2023
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
PDF
Supplementary Figure 1 from Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2023
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
PDF
Supplementary Figure 2 from Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2023
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
Data from Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
2023
·
Diana M. Cittelly
, Irina Dimitrova
, et al.
Abstract 4091: Functional genomic screening in gemcitabine and cisplatin resistant bladder cancer cell lines identifies DNA repair pathways as mediators of chemosensitivity
2020
·
Robert T. Jones
, Tahlita C. Zuiverloon
, et al.
·
Cancer Research
Show more works
View as search
Works count:
29
Citation count:
1,108
H-index:
9
I10-index:
9
Year
Topic
Type